Global | Coronavirus Watch: The limits of vaccines
Vaccines are the key to a safe and permanent transition to more normal conditions. But evidence from economies that already have implemented widespread vaccine rollouts confirms our long-held view that high vaccination rates will not be the sole factor.
Of the 20 economies that have delivered the swiftest rollouts, nine are small states with patchy data. Of the remaining 11, only five now have lower daily Covid cases than they did at the point they began vaccinations. On mortality rates, the equivalent figure is just six.
Lockdown stringency scores suggest an over-eagerness to lift restrictions has not necessarily been the reason for the worsening health situation in some of these economies. Also, the presence of several new variants in the UK, US, and Israel, which have recorded large falls in cases and deaths this year, suggests the spread of variants isn’t solely to blame.
Estimates that the first dose of the Sinopharm vaccine may be just 3% effective in preventing infection could explain why some economies have seen high vaccine take-up but surging cases. And new variants may have reduced the efficacy of some individual vaccines, also lowering immunity.
In all, the experiences of economies such as Israel provides grounds for optimism. But at the same time, developments in other economies show that a corner will not be turned simply by reaching a specific vaccine threshold.
Firms must brace for higher ‘new normal’ construction material prices
New research by Oxford Economics suggests that construction materials prices have shifted permanently higher due to the shocks of the past couple of years. Project managers and investors should anticipate costs being at least 15-20% higher in 2024 and onwards than in 2021.Find Out More
New Activity Trackers suggest momentum is waning
After a choppy first quarter of GDP data, our novel Activity Trackers (which incorporate proprietary daily sentiment data from Penta) suggest that economic momentum in EM Asia is on a softer trend in Q2 (at least outside of China) supporting our view of easing underlying inflationary pressures and diminishing appetite for further rate hikes.Find Out More